TY - JOUR
T1 - Middle-down proteomics
T2 - a still unexploited resource for chromatin biology
AU - Sidoli, Simone
AU - Garcia, Benjamin A.
N1 - Funding Information:
This manuscript was produced thanks to funding from the U.S. Department of Health and Human Services, National Institute of Health grants R01GM110174 (BG) and P01CA196539(BG); the U.S. Department of Defense, grant W81XWH-113-1-0426(BG) and from the Leukemia and Lymphoma Society, Dr. Robert Arceci Scholar Award(BG).
Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2017/7/3
Y1 - 2017/7/3
N2 - Introduction: Analysis of histone post-translational modifications (PTMs) by mass spectrometry (MS) has become a fundamental tool for the characterization of chromatin composition and dynamics. Histone PTMs benchmark several biological states of chromatin, including regions of active enhancers, active/repressed gene promoters and damaged DNA. These complex regulatory mechanisms are often defined by combinatorial histone PTMs; for instance, active enhancers are commonly occupied by both marks H3K4me1 and H3K27ac. The traditional bottom-up MS strategy identifies and quantifies short (aa 4–20) tryptic peptides, and it is thus not suitable for the characterization of combinatorial PTMs. Areas covered: Here, we review the advancement of the middle-down MS strategy applied to histones, which consists in the analysis of intact histone N-terminal tails (aa 50–60). Middle-down MS has reached sufficient robustness and reliability, and it is far less technically challenging than PTM quantification on intact histones (top-down). However, the very few chromatin biology studies applying middle-down MS resulting from PubMed searches indicate that it is still very scarcely exploited, potentially due to the apparent high complexity of method and analysis. Expert commentary: We will discuss the state-of-the-art workflow and examples of existing studies, aiming to highlight its potential and feasibility for studies of cell biologists interested in chromatin and epigenetics.
AB - Introduction: Analysis of histone post-translational modifications (PTMs) by mass spectrometry (MS) has become a fundamental tool for the characterization of chromatin composition and dynamics. Histone PTMs benchmark several biological states of chromatin, including regions of active enhancers, active/repressed gene promoters and damaged DNA. These complex regulatory mechanisms are often defined by combinatorial histone PTMs; for instance, active enhancers are commonly occupied by both marks H3K4me1 and H3K27ac. The traditional bottom-up MS strategy identifies and quantifies short (aa 4–20) tryptic peptides, and it is thus not suitable for the characterization of combinatorial PTMs. Areas covered: Here, we review the advancement of the middle-down MS strategy applied to histones, which consists in the analysis of intact histone N-terminal tails (aa 50–60). Middle-down MS has reached sufficient robustness and reliability, and it is far less technically challenging than PTM quantification on intact histones (top-down). However, the very few chromatin biology studies applying middle-down MS resulting from PubMed searches indicate that it is still very scarcely exploited, potentially due to the apparent high complexity of method and analysis. Expert commentary: We will discuss the state-of-the-art workflow and examples of existing studies, aiming to highlight its potential and feasibility for studies of cell biologists interested in chromatin and epigenetics.
KW - Chromatin
KW - cross-talk
KW - histones
KW - mass spectrometry
KW - middle-down
KW - post-translational modifications
KW - proteomics
UR - http://www.scopus.com/inward/record.url?scp=85021744812&partnerID=8YFLogxK
U2 - 10.1080/14789450.2017.1345632
DO - 10.1080/14789450.2017.1345632
M3 - Review article
C2 - 28649883
AN - SCOPUS:85021744812
SN - 1478-9450
VL - 14
SP - 617
EP - 626
JO - Expert Review of Proteomics
JF - Expert Review of Proteomics
IS - 7
ER -